FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2176138279> ?p ?o ?g. }

• W2176138279 endingPage "939" @default.
• W2176138279 startingPage "928" @default.
• W2176138279 abstract "PurposeRecombinant human bone morphogenetic protein-2 (rhBMP-2) is approved by the Food and Drug Administration as a viable alternative to bone graft in spinal fusion and maxillary sinus lift. The research questions for meta-analysis were: Is rhBMP-2 an effective bone graft substitute in localized alveolar ridge augmentation and maxillary sinus floor augmentation? What are the potential adverse events?Materials and MethodsA search of MEDLINE from January 1980 to January 2014 using PubMed, the Cochrane Database of Systematic Reviews and Controlled Trials, CINAHL, and EMBASE was performed. Searches were performed from Medical Subject Headings. The quality of each study included was graded by Review Manager software. The primary outcome variable was bone formation measured as change in bone height on computed tomogram. A systematic review of adverse events also was performed. A random-effects model was chosen. Continuous variables were calculated using the standardized mean difference and 95% confidence intervals (CIs) comparing improvement from baseline of the experimental group with that of the control group. Change in bone height was calculated using logarithmic odds ratio. Test of significance used the Z statistic with a P value of .05.ResultsTen studies met the criteria for systematic review; 8 studies were included in the meta-analysis. Five studies assessed localized alveolar ridge augmentation and resulted in an overall standardized mean difference of 0.56 (CI, 0.20-0.92) in favor of BMP; this result was statistically important. Three studies assessed maxillary sinus floor augmentation and resulted in an overall standardized mean difference of −0.50 (CI, −0.93 to −0.09), which was meaningfully different in favor of the control group. Adverse events were inconsistently reported, ranging from no complications to widespread adverse events.ConclusionFor localized alveolar ridge augmentation, this meta-analysis showed that rhBMP-2 substantially increases bone height. However, rhBMP-2 does not perform as well as the autograft or allograft in maxillary sinus floor augmentation. Long-term clinical success and adverse events need to be reported with more consistency before definitive conclusions can be made. Recombinant human bone morphogenetic protein-2 (rhBMP-2) is approved by the Food and Drug Administration as a viable alternative to bone graft in spinal fusion and maxillary sinus lift. The research questions for meta-analysis were: Is rhBMP-2 an effective bone graft substitute in localized alveolar ridge augmentation and maxillary sinus floor augmentation? What are the potential adverse events? A search of MEDLINE from January 1980 to January 2014 using PubMed, the Cochrane Database of Systematic Reviews and Controlled Trials, CINAHL, and EMBASE was performed. Searches were performed from Medical Subject Headings. The quality of each study included was graded by Review Manager software. The primary outcome variable was bone formation measured as change in bone height on computed tomogram. A systematic review of adverse events also was performed. A random-effects model was chosen. Continuous variables were calculated using the standardized mean difference and 95% confidence intervals (CIs) comparing improvement from baseline of the experimental group with that of the control group. Change in bone height was calculated using logarithmic odds ratio. Test of significance used the Z statistic with a P value of .05. Ten studies met the criteria for systematic review; 8 studies were included in the meta-analysis. Five studies assessed localized alveolar ridge augmentation and resulted in an overall standardized mean difference of 0.56 (CI, 0.20-0.92) in favor of BMP; this result was statistically important. Three studies assessed maxillary sinus floor augmentation and resulted in an overall standardized mean difference of −0.50 (CI, −0.93 to −0.09), which was meaningfully different in favor of the control group. Adverse events were inconsistently reported, ranging from no complications to widespread adverse events. For localized alveolar ridge augmentation, this meta-analysis showed that rhBMP-2 substantially increases bone height. However, rhBMP-2 does not perform as well as the autograft or allograft in maxillary sinus floor augmentation. Long-term clinical success and adverse events need to be reported with more consistency before definitive conclusions can be made." @default.
• W2176138279 created "2016-06-24" @default.
• W2176138279 creator A5007744576 @default.
• W2176138279 creator A5011962548 @default.
• W2176138279 creator A5036452115 @default.
• W2176138279 date "2016-05-01" @default.
• W2176138279 modified "2023-10-07" @default.
• W2176138279 title "Systematic Review and Meta-Analysis of Recombinant Human Bone Morphogenetic Protein-2 in Localized Alveolar Ridge and Maxillary Sinus Augmentation" @default.
• W2176138279 cites W1852943991 @default.
• W2176138279 cites W1966469600 @default.
• W2176138279 cites W2007872832 @default.
• W2176138279 cites W2009638772 @default.
• W2176138279 cites W2014525158 @default.
• W2176138279 cites W2032772487 @default.
• W2176138279 cites W2039839585 @default.
• W2176138279 cites W2040559804 @default.
• W2176138279 cites W2052948656 @default.
• W2176138279 cites W2074645659 @default.
• W2176138279 cites W2075951292 @default.
• W2176138279 cites W2094920892 @default.
• W2176138279 cites W2099453231 @default.
• W2176138279 cites W2102878228 @default.
• W2176138279 cites W2114488753 @default.
• W2176138279 cites W2120033390 @default.
• W2176138279 cites W2129464489 @default.
• W2176138279 cites W2132161915 @default.
• W2176138279 cites W2155267255 @default.
• W2176138279 cites W2168818928 @default.
• W2176138279 doi "https://doi.org/10.1016/j.joms.2015.11.027" @default.
• W2176138279 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26707429" @default.
• W2176138279 hasPublicationYear "2016" @default.
• W2176138279 type Work @default.
• W2176138279 sameAs 2176138279 @default.
• W2176138279 citedByCount "54" @default.
• W2176138279 countsByYear W21761382792016 @default.
• W2176138279 countsByYear W21761382792017 @default.
• W2176138279 countsByYear W21761382792018 @default.
• W2176138279 countsByYear W21761382792019 @default.
• W2176138279 countsByYear W21761382792020 @default.
• W2176138279 countsByYear W21761382792021 @default.
• W2176138279 countsByYear W21761382792022 @default.
• W2176138279 countsByYear W21761382792023 @default.
• W2176138279 crossrefType "journal-article" @default.
• W2176138279 hasAuthorship W2176138279A5007744576 @default.
• W2176138279 hasAuthorship W2176138279A5011962548 @default.
• W2176138279 hasAuthorship W2176138279A5036452115 @default.
• W2176138279 hasBestOaLocation W21761382791 @default.
• W2176138279 hasConcept C126322002 @default.
• W2176138279 hasConcept C141071460 @default.
• W2176138279 hasConcept C156957248 @default.
• W2176138279 hasConcept C172829275 @default.
• W2176138279 hasConcept C197934379 @default.
• W2176138279 hasConcept C199343813 @default.
• W2176138279 hasConcept C2778705571 @default.
• W2176138279 hasConcept C2779127617 @default.
• W2176138279 hasConcept C2781411149 @default.
• W2176138279 hasConcept C28804328 @default.
• W2176138279 hasConcept C44249647 @default.
• W2176138279 hasConcept C71924100 @default.
• W2176138279 hasConcept C95190672 @default.
• W2176138279 hasConceptScore W2176138279C126322002 @default.
• W2176138279 hasConceptScore W2176138279C141071460 @default.
• W2176138279 hasConceptScore W2176138279C156957248 @default.
• W2176138279 hasConceptScore W2176138279C172829275 @default.
• W2176138279 hasConceptScore W2176138279C197934379 @default.
• W2176138279 hasConceptScore W2176138279C199343813 @default.
• W2176138279 hasConceptScore W2176138279C2778705571 @default.
• W2176138279 hasConceptScore W2176138279C2779127617 @default.
• W2176138279 hasConceptScore W2176138279C2781411149 @default.
• W2176138279 hasConceptScore W2176138279C28804328 @default.
• W2176138279 hasConceptScore W2176138279C44249647 @default.
• W2176138279 hasConceptScore W2176138279C71924100 @default.
• W2176138279 hasConceptScore W2176138279C95190672 @default.
• W2176138279 hasIssue "5" @default.
• W2176138279 hasLocation W21761382791 @default.
• W2176138279 hasLocation W21761382792 @default.
• W2176138279 hasOpenAccess W2176138279 @default.
• W2176138279 hasPrimaryLocation W21761382791 @default.
• W2176138279 hasRelatedWork W2104799573 @default.
• W2176138279 hasRelatedWork W2351825573 @default.
• W2176138279 hasRelatedWork W2470651619 @default.
• W2176138279 hasRelatedWork W2546966958 @default.
• W2176138279 hasRelatedWork W2627066064 @default.
• W2176138279 hasRelatedWork W2752828407 @default.
• W2176138279 hasRelatedWork W2915506953 @default.
• W2176138279 hasRelatedWork W2996133010 @default.
• W2176138279 hasRelatedWork W3033051562 @default.
• W2176138279 hasRelatedWork W4210685590 @default.
• W2176138279 hasVolume "74" @default.
• W2176138279 isParatext "false" @default.
• W2176138279 isRetracted "false" @default.
• W2176138279 magId "2176138279" @default.
• W2176138279 workType "article" @default.